Nu-V3 initiatives for expanded uses are designed to treat those in need, demonstrate the safety, effectiveness and ease of use for Nu-V3 and creating demand as we prepare for market entry. The Nu-Life Medical Alliance is focused on these new uses as we enter the market for symptom management.
As Nu-Life prepares Nu-V3 for market entry, treating the symptoms of pain, anxiety, depression and sleeplessness, these expanded uses offer the greatest opportunity for success as we also extend our market entry beyond the United States to Europe, Japan, Latin America and Canada, all regions where Nu-Life holds patents for Nu-V3.
Mental Health
There’s so much focus recently on mental health whether it be depression, anxiety, sleeplessness from an adverse event maybe due to COVID-19 or the effects of Covid-19 or an elite athlete such as a tennis player, or Olympic gymnast taking taking time to address their mental health. There’s never been a more important time to consider the possibilities of treatment whether they be physical or emotional or therapeutic.
Welcome Dr. Kennette Thigpen, who joins us to strengthen the handshake between physical treatment for anxiety depression and sleeplessness and therapeutic treatment options.
Rheumatology
Arthritis, rheumatoid arthritis and fibromyalgia. These are a few of the chronic rheumatic conditions we addressing through our next set of clinical programs, directed by our Executive Medical Team member, Dr. Kamran Chaudhary.
After more than ten years of collaboration with Nu-Life, to perfect our technology, we are very excited to soon demonstrate how Nu-V3 and the Nu-V3 Treatment Program will deliver relief among these patient populations.
Opioid Addiction
For years, we have understood the ability of Nu-V3 to mitigate or eliminate the need for some pain medications, especially opioids. This remains an integral element to the Nu-V3 treatment and delivery of long term relief from the debilitating symptoms of pain, anxiety, depression and sleeplessness.
We are happy to announce the expansion of the use of Nu-V3 focused specifically on opioid addiction. Our resident expert, Dr. John Rosa, will be overseeing this initiative. Dr. Rosa regularly speaks on addiction and we are happy to demonstrate Nu-V3 as part of the solution.
Post-op Surgery and Recovery
The mechanisms of action behind the science makes post op recovery an exciting application for Nu-V3 and the Nu-V3 Treatment Program. Accelerated recovery immediately after surgery as well as in the weeks following, along with the mitigation or even elimination of pain medications, makes Nu-V3 a natural for this expanded use.
Nu-Life Executive Medical Directors, Dr Rick Rosa and Dr. John Rosa will team up for this clinical program to demonstrate the use of Nu-V3, addressing both recovery and the use of medications known to lead to dependancy.
Elite Performance
One of the most exciting opportunities for expanded use of Nu-V3 is in the field of sports medicine. While pain management and recovery from injury are know benefits from Nu-V3, significant improvement in performance in elite athletes and active military are at the forefront of our research on the mechanisms of action behind Nu-V3. More about some exciting collaborations soon!
Dr. Rick Rosa, one of our newest Medical Alliance members will be collaborating with Dr. Kennette Thigpen on the physical as well as the mental aspect of elite performance.
Neurodegerative
Following the science of Nu-V3 and the manner in which neuromodulation is achieved there is hope that Nu-V3 may offer some relief for those suffering from neurodegenerative disease.
With our symptom management initiatives well underway, we are now able to widen our focus on research, utilizing Nu-V3 and the Nu-V3 Treatment Program on specific areas of neurodegenerative diseases such as Parkinson's and Alzheimer's.
Cardiovascular Disease (AFib)
More than 12 million people suffer from atrial fibrillation (AFib) in the United States alone. The combination of our Nu-V3 treatment program and heart rate variability tracking, offer encourag-ement for significant improvement of AFib and associated symptoms.
Nu-Life is in the process of engaging with leading cardiologists and researchers to determine just how Nu-V3 may help.